Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Check out this Tweet as well
$NXEN had mentioned the #FDA pathway for Myotonic Dystrophies and Myotonia in the 10-K, saying it "may fall under the Orphan Drug Act of 1983".
— OwnTheFloat.com (@OwnTheFloat) November 6, 2018
That's the next PR I'm hoping to hear about in relation to Dr. Schoser's area of research. :)#MJOTCS #CannabisStocks #MarijuanaStocks pic.twitter.com/NyUI1XlwyM
Hi Zenguy,
I like hearing updates from the companies I invest in. I Tweeted this morning where I highlighted some key sentences:
$NXEN NEWS!
— OwnTheFloat.com (@OwnTheFloat) November 6, 2018
"Nexien BioPharma Advances in Clinical Use of a Cannabinoid-Based Formulation for the Treatment of Myotonic Dystrophies and Myotonia"#MJOTCS #CannabisStocks #PotStocks #MarijuanaStocks #Biotech #OTC #StocksToWatchhttps://t.co/HrIYQHTWDO pic.twitter.com/cg1AUKPaMA
I wanted to point out -- I mentioned taking profits at $9.00 if there wasn't some kind of massive news to justify it.
GWPH was sitting over $3 Billion for a while before their FDA approval because they were getting closer and closer.
If NXEN were to receive some kind of FDA approval to proceed with clinical studies under Orphan Drug exemption to where "total approval" is more streamlined -- I may not want to sell much at $9.00 as crazy as that sounds.
Why? Because as I mentioned... $9.00 is roughly $500 million. If I suspect $1 billion market cap could be months away because of timelines given to us by management, I may just be willing to wait it out. :)
$18/share is oh, so much sweeter than $9/share. LOL.
P.S. I hope what I'm saying isn't being confused with pumping. These scenarios are based on LEGIT, BIG NEWS / MILESTONES!
If we run to $9.00 because of the Canadian listing and starting a clinical study -- I'll be "taking profits" and waiting for lower re-entry because I then believe I may have time to get back in.
Obviously with as many 'projects' NXEN has in their pipeline -- it may be a mistake to think it'll come back down too far and I may just end up chasing -- but at that point I will learn to BE UNBELIEVABLY HAPPY with the profit at $9.00 :)
HOWEVER! The drop from $4.00 to $0.38 was because NTVA/NXEN did a reverse merger with KDRH and then a reverse split.
There was such a tiny amount of shares (247,225 to be exact) available prior to the 2,463,466 that were registered via the S-1 on June 28, 2018.
You can look NASDAQ’s Historical Stock Price site to verify the volume and share price on each day.
https://www.nasdaq.com/symbol/nxen/historical
It wasn’t until July 10, 2018 that NTVA finally saw some volume from the newly unrestricted shares. That’s also the day the share price went from $3.44 to $1.55 before closing at $2.00.
As time went on and more shares were moved from Transfer Agent to Brokers, the volume got higher and the price dropped to a more realistic figure in terms of Market Cap.
I have not yet, no.
May start to dive into that next week -- have a funeral tomorrow and it's 3 hours travel each direction.
$NXEN management has Pfizer, J&J, Merck on their resumes!
Connections also with Ebbu, who was just acquired by Canopy Growth ($CGC)
Check out the DD at http://ownthefloat.com/index.php/2018/11/03/nxen-acquisition-of-crx-bio-holdings-brings-more-great-management/
People were impressed with $RCGP because of "Ray Grimm". While Mr. Grimm is impressive -- he's one man and he hasn't been part of Big Pharma. ;)
If $RCGP was able to run to $1.6 Billion market cap as a start-up without current SEC filings... I would sure as hell hope $NXEN can run beyond $500M after their CSE cross-list and some updates related to their drug research & development. Especially when their Annual Report talked about FDA communication already.
$NXEN management has Pfizer, J&J, Merck on their resumes!
Connections also with Ebbu, who was just acquired by Canopy Growth ($CGC)
Check out the DD at http://ownthefloat.com/index.php/2018/11/03/nxen-acquisition-of-crx-bio-holdings-brings-more-great-management/
People were impressed with $RCGP because of "Ray Grimm". While Mr. Grimm is impressive -- he's one man and he hasn't been part of Big Pharma. ;)
If $RCGP was able to run to $1.6 Billion market cap as a start-up without current SEC filings... I would sure as hell hope $NXEN can run beyond $500M after their CSE cross-list and some updates related to their drug research & development. Especially when their Annual Report talked about FDA communication already.
$NXEN management has Pfizer, J&J, Merck on their resumes!
Connections also with Ebbu, who was just acquired by Canopy Growth ($CGC)
Check out the DD at http://ownthefloat.com/index.php/2018/11/03/nxen-acquisition-of-crx-bio-holdings-brings-more-great-management/
People were impressed with $RCGP because of "Ray Grimm". While Mr. Grimm is impressive -- he's one man and he hasn't been part of Big Pharma. ;)
If $RCGP was able to run to $1.6 Billion market cap as a start-up without current SEC filings... I would sure as hell hope $NXEN can run beyond $500M after their CSE cross-list and some updates related to their drug research & development. Especially when their Annual Report talked about FDA communication already.
$NXEN management has Pfizer, J&J, Merck on their resumes!
Connections also with Ebbu, who was just acquired by Canopy Growth ($CGC)
Check out the DD at http://ownthefloat.com/index.php/2018/11/03/nxen-acquisition-of-crx-bio-holdings-brings-more-great-management/
People were impressed with $RCGP because of "Ray Grimm". While Mr. Grimm is impressive -- he's one man and he hasn't been part of Big Pharma. ;)
If $RCGP was able to run to $1.6 Billion market cap as a start-up without current SEC filings... I would sure as hell hope $NXEN can run beyond $500M after their CSE cross-list and some updates related to their drug research & development. Especially when their Annual Report talked about FDA communication already.
New Blog! "Acquisition of CRx Bio Holdings Brings MORE Great Management!"
http://ownthefloat.com/index.php/2018/11/03/nxen-acquisition-of-crx-bio-holdings-brings-more-great-management/
Sounds like you guys touched on this, but if there's any confusion as to whether or not yesterday's FORM 3 has you thinking it's in the Float -- it's absolutely NOT in the Float.
The FORM 3 even states, "30% of the shares will be released from forfeiture restrictions beginning October 26, 2019 and on each of the next two anniversaries." at the bottom.
If they're restricted, they are not in the Float.
I'm 99.9% confident the Float is increasing because some of the 64 initial investors listed on the June S-1.
Again, I can't prove it, but I strongly suspect MOST of these initial investors are holding for actual news but I don't doubt some of them grew impatient since they invested back in June 2017.
That's ~500 days ago. 72 weeks. 1 Year & 4 Months.
So, yes, they're making a profit selling for $0.40 -- but I think they're silly for not waiting another few weeks, as it's pretty obvious they're assembling something very special here.
"All in my opinion", based on the obvious facts.
16,500 Buy at 0.50 via Form T just after close.
https://ih.advfn.com/stock-market/USOTC/nexien-biopharma-inc-NXEN/trades
What is a Form T?
In the OTC market, Form T trades are mostly the result of accumulated buys or sells handled on a not held basis by block desks, otherwise known as 'late prints.' They have nothing to do with short-selling. Large blocks of shares may not all be sold in a single day, so a broker or market maker would file a Form T for the remainder of shares listed at the average price that day's shares sold for as if they all had sold. If all the shares had sold in that one session, the transaction would have been recorded normally.
It's POSSIBLE that some of the original 'random investors' who bought way back in June/July 2017 have been selling. They still made a return at $0.40. That's probably better they're selling now anyway if that's the case. We build a stronger base higher up so they don't ruin the run as quickly. :)
But, either way, you're right about lacking patience... It's pretty obvious this is going to be going places -- possibly as soon as November, given the extension on the $1.00 warrants expiring at the end of November.
I'll gladly hold and even add some more here and there in this range.
$NXEN Acquisition News! They've acquired CRX Bio Holdings -- their management, their assets, their 3 provisional patent applications.
The management from CRX includes a VP of Pharma Development for $TEVA! The new CEO has almost 10 years with Elevated Life Sciences. Lots of goodies here.
Great, up and coming Medical Cannabis with a CSE cross list around the corner and a tiny 1.5M verified and mostly locked float as of last week!
Do your DD here! You'll see... www.NexienBiopharma.com
$NXEN Acquisition News! They've acquired CRX Bio Holdings -- their management, their assets, their 3 provisional patent applications.
The management from CRX includes a VP of Pharma Development for $TEVA! The new CEO has almost 10 years with Elevated Life Sciences. Lots of goodies here.
Great, up and coming Medical Cannabis with a CSE cross list around the corner and a tiny 1.5M verified and mostly locked float as of last week!
Do your DD here! You'll see... www.NexienBiopharma.com
$NXEN Acquisition News! They've acquired CRX Bio Holdings -- their management, their assets, their 3 provisional patent applications.
The management from CRX includes a VP of Pharma Development for $TEVA! The new CEO has almost 10 years with Elevated Life Sciences. Lots of goodies here.
Great, up and coming Medical Cannabis with a CSE cross list around the corner and a tiny 1.5M verified and mostly locked float as of last week!
Do your DD here! You'll see... www.NexienBiopharma.com
Robert McKean, Ph.D was VP Pharmaceutical Development at TEVA!
This man is part of the NXEN Advisory Board!
https://nexienbiopharma.com/advisory_board
Considering the August 22nd PR about the filing and a guy at the CSE telling me a 'general timeline' that fell around October 18th -- I suspect it has to be announced soon.
CRX was a beautiful addition.
RCGP had excitement because ONE guy had a successful business background. NXEN has a tremendous amount of stellar people in their organization and CRX only added to that.
The future is bright here. No "pumping" required -- just relaying the facts should be enough to wake people up. Some day. They'll figure it out.
That was the day of the ticker change when it got the attention of far more people finally. NTVA was pretty quiet and under the radar. Still is, for the most part.
Huge volume came in the day of the new ticker. Low float (1.5m) stocks will definitely do that on volume.
Also, the higher share price before the drop towards 0.50 was when they had done their R/M and then R/S. Once that happened, there were virtually no shares available for trading other than the left overs from KDRH. You can check filings for the S-1 and see it matches up with the drop.
When AXIM, OWCP, and CNBX ran massively... Their floats were far larger than what NXEN could be in a worst case scenario.
We're fine either way when people figure it out.
I have her email address. I'll email every few days or maybe once a week. Haha.
The highest it'll get if the CEO, COO, Chairman, CFO, and other Big Ass Investors were to transfer is still only 15.6 million.
That's still a pretty damn small float.
But, again, I think we can all agree many millions will NOT be transferred to a Broker ant time soon.
True. However, the float only increases when people transfer shares to brokers.
I strongly suspect most of the big wigs aren't transferring any time soon.
Investors INVEST. They hold. They wait for years without giving a crap about day to day swings.
So, it may take months to increase to even 5M shares in the float.
In my opinion. :)
$NXEN - 1.5M Float Colorado-based Medical Cannabis!
- Medical Cannabis with Patents Filed for Multiple Areas of Research
- Great Management Line-Up
...... Alain Bankier is successful investor overall. Speaker at Cannabis Investor conferences too.
...... Lindy Snider is Founder of cancer patient skin care line and daughter of a Billionaire
...... Kevin McGovern from SoBe Beverages, sold to Coke for $370M
- 1.5M FLOAT (Confirmed by Standard Transfer on 10/23/18) and 44.5M O/S
- Canadian cross list any day (See PR from 8/22)
- Possible FDA related news soon (See PR from June/July and the 10-K)
Some basic DD with links: http://ownthefloat.com/index.php/2018/07/29/ntva-heres-why-i-invested-in-intiva-biopharma/
$NXEN - 1.5M FLOAT Medical Cannabis! Likely not under $0.75 for long, I assume.
- Medical Cannabis with Patents Filed for Multiple Areas of Research
- Great Management Line-Up
...... Alain Bankier is successful investor overall. Speaker at Cannabis Investor conferences too.
...... Lindy Snider is Founder of cancer patient skin care line and daughter of a Billionaire
...... Kevin McGovern from SoBe Beverages, sold to Coke for $370M
- 1.5M FLOAT (Confirmed by Standard Transfer on 10/23/18) and 44.5M O/S
- Canadian cross list any day (See PR from 8/22)
- Possible FDA related news soon (See PR from June/July and the 10-K)
Some basic DD with links: http://ownthefloat.com/index.php/2018/07/29/ntva-heres-why-i-invested-in-intiva-biopharma/
$NXEN - 1.5M FLOAT Medical Cannabis! Thought I'd spread the word while at $0.63. :)
- Medical Cannabis with Patents Filed for Multiple Areas of Research
- Great Management Line-Up
...... Alain Bankier is successful investor overall. Speaker at Cannabis Investor conferences too.
...... Lindy Snider is Founder of cancer patient skin care line and daughter of a Billionaire
...... Kevin McGovern from SoBe Beverages, sold to Coke for $370M
- 1.5M FLOAT (Confirmed by Standard Transfer on 10/23/18) and 44.5M O/S
- Canadian cross list any day (See PR from 8/22)
- Possible FDA related news soon (See PR from June/July and the 10-K)
Some basic DD with links: http://ownthefloat.com/index.php/2018/07/29/ntva-heres-why-i-invested-in-intiva-biopharma/
$NXEN - 1.5M FLOAT Medical Cannabis!
- Medical Cannabis with Patents Filed for Multiple Areas of Research
- Great Management Line-Up
...... Alain Bankier is successful investor overall. Speaker at Cannabis Investor conferences too.
...... Lindy Snider is Founder of cancer patient skin care line and daughter of a Billionaire
...... Kevin McGovern from SoBe Beverages, sold to Coke for $370M
- 1.5M FLOAT (Confirmed by Standard Transfer on 10/23/18) and 44.5M O/S
- Canadian cross list any day (See PR from 8/22)
- Possible FDA related news soon (See PR from June/July and the 10-K)
Some basic DD with links: http://ownthefloat.com/index.php/2018/07/29/ntva-heres-why-i-invested-in-intiva-biopharma/
$NXEN - 1.5M FLOAT Medical Cannabis!
- Medical Cannabis with Patents Filed for Multiple Areas of Research
- Great Management Line-Up
...... Alain Bankier is successful investor overall. Speaker at Cannabis Investor conferences too.
...... Lindy Snider is Founder of cancer patient skin care line and daughter of a Billionaire
...... Kevin McGovern from SoBe Beverages, sold to Coke for $370M
- 1.5M FLOAT (Confirmed by Standard Transfer on 10/23/18) and 44.5M O/S
- Canadian cross list any day (See PR from 8/22)
- Possible FDA related news soon (See PR from June/July and the 10-K)
Some basic DD with links: http://ownthefloat.com/index.php/2018/07/29/ntva-heres-why-i-invested-in-intiva-biopharma/
$NXEN - 1.5M FLOAT Medical Cannabis!
- Medical Cannabis with Patents Filed for Multiple Areas of Research
- Great Management Line-Up
...... Alain Bankier is successful investor overall. Speaker at Cannabis Investor conferences too.
...... Lindy Snider is Founder of cancer patient skin care line and daughter of a Billionaire
...... Kevin McGovern from SoBe Beverages, sold to Coke for $370M
- 1.5M FLOAT (Confirmed by Standard Transfer on 10/23/18) and 44.5M O/S
- Canadian cross list any day (See PR from 8/22)
- Possible FDA related news soon (See PR from June/July and the 10-K)
Some basic DD with links: http://ownthefloat.com/index.php/2018/07/29/ntva-heres-why-i-invested-in-intiva-biopharma/
$NXEN - 1.5M FLOAT Medical Cannabis!
- Medical Cannabis with Patents Filed for Multiple Areas of Research
- Great Management Line-Up
...... Alain Bankier is successful investor overall. Speaker at Cannabis Investor conferences too.
...... Lindy Snider is Founder of cancer patient skin care line and daughter of a Billionaire
...... Kevin McGovern from SoBe Beverages, sold to Coke for $370M
- 1.5M FLOAT (Confirmed by Standard Transfer on 10/23/18) and 44.5M O/S
- Canadian cross list any day (See PR from 8/22)
- Possible FDA related news soon (See PR from June/July and the 10-K)
Some basic DD with links: http://ownthefloat.com/index.php/2018/07/29/ntva-heres-why-i-invested-in-intiva-biopharma/
This website has been around since 2011 too. You can see what it looked like back in 2011 by going here -- https://web.archive.org/web/20110808192307/http://peoplebeatingcancer.org/
You know, for the sake of "proving credibility". :)
Yup, confirmed it for myself with Brandy at Standard Registrar & Transfer:
Phone: 801-571-8844
Standard Registrar & Transfer Co., Inc.
440 East 400 South
Suite 200
Salt Lake City, UT 84111
One possibility... Initial investors got in June 2017. Some may finally be pulling some profits.
No biggie. Replacing low entry base with new, higher base for higher places.
$NXEN has everything you'd expect of a runner stock, IMO!
- Medical Cannabis with Patents Filed for Multiple Areas of Research
- Great Management Line-Up (Alain Bankier (successful investor overall), Lindy Snider is Founder of cancer patient skin care line and daughter of a Billionaire), Kevin McGovern from SoBe, etc.)
- 2.7M FLOAT (Likely 1.25M being available, per S-1) and 44.5M O/S
- Ticker Change as of 10/19/18
- Canadian cross list any day (See PR from 8/22)
- Possible FDA related news soon (See PR from June/July and the 10-K)
Some basic DD with links: http://ownthefloat.com/index.php/2018/07/29/ntva-heres-why-i-invested-in-intiva-biopharma/
$NXEN has everything you'd expect of a runner stock, IMO!
- Medical Cannabis with Patents Filed for Multiple Areas of Research
- Great Management Line-Up (Alain Bankier (successful investor overall), Lindy Snider is Founder of cancer patient skin care line and daughter of a Billionaire), Kevin McGovern from SoBe, etc.)
- 2.7M FLOAT (Likely 1.25M being available, per S-1) and 44.5M O/S
- Ticker Change as of 10/19/18
- Canadian cross list any day (See PR from 8/22)
- Possible FDA related news soon (See PR from June/July and the 10-K)
Some basic DD with links: http://ownthefloat.com/index.php/2018/07/29/ntva-heres-why-i-invested-in-intiva-biopharma/
Just for comparison sake since this is the 10 Bagger board... $0.89 to $8.90 is doable when you look at other medical cannabis runners: OWCP, CNBX, AXIM, and even the 'start-up' RCGP that has gone bonkers.
$NXEN has everything you'd expect of a runner stock, IMO!
- Medical Cannabis with Patents Filed for Multiple Areas of Research
- Great Management Line-Up (Alain Bankier (successful investor overall), Lindy Snider is Founder of cancer patient skin care line and daughter of a Billionaire), Kevin McGovern from SoBe, etc.)
- 2.7M FLOAT (Likely 1.25M being available, per S-1) and 44.5M O/S
- Ticker Change as of 10/19/18
- Canadian cross list any day (See PR from 8/22)
- Possible FDA related news soon (See PR from June/July and the 10-K)
Some basic DD with links: http://ownthefloat.com/index.php/2018/07/29/ntva-heres-why-i-invested-in-intiva-biopharma/
Hell yeah. It's only logical that they have a development since July with that aspect of research.
You file patents after you've made your discovery as to protect it from being ripped off.
Then, you retain a world-renowned expert Doctor less than a month later? Not "for the hell of it", but because YOU'RE ONTO SOMETHING and need the best guidance. :)
Geez, 5000%? Amazing.
0.89 to 10.00 is "only" 1023.5%. Haha.
I've used Fidelity.
Yeah, I'm patient. Whatever happens, happens.